Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEOBiotechnology
Healthcare
$2.95 -0.94%
-$0.05 today
- Market cap
- $244.23M
- Beta
- 1.39
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$1.08
52W Low $3.60High $10.99
Volume 1.76M
Average 0.86M
Price history
Lexeo Therapeutics, Inc. Common Stock SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-67.55%
Period high
$10.63
Period low
$2.63
Latest
$2.95
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 13, 2026 | Nov 13, 2026 | |
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| EFFECT | Nov 4, 2026 | Nov 5, 2026 | |
| S-3 | Oct 29, 2026 | Oct 29, 2026 | |
| SC 13G | Oct 13, 2026 | Oct 13, 2026 | |
| 8-K | Sep 29, 2026 | Sep 29, 2026 | |
| 4 | Sep 28, 2026 | Sep 28, 2026 | |
| 4 | Sep 28, 2026 | Sep 28, 2026 | |
| 4 | Sep 28, 2026 | Sep 28, 2026 | |
| 4 | Sep 28, 2026 | Sep 28, 2026 | |
| 8-K | Sep 22, 2026 | Sep 22, 2026 | |
| 4 | Aug 19, 2026 | Aug 19, 2026 | |
| 4 | Aug 19, 2026 | Aug 19, 2026 | |
| 4 | Aug 19, 2026 | Aug 19, 2026 | |
| 144 | Aug 18, 2026 | Aug 18, 2026 |
Competitors
Who does Lexeo Therapeutics, Inc. Common Stock compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about LXEO's filings, answered from its disclosures.
What is the latest LXEO filing?
The latest filing shown is SC 13G/A dated Nov 13, 2026.
How many recent filings does LXEO have?
Intrinsic Alpha currently shows 20 recent filings for LXEO.
Continue the stock analysis
Jump to another research area for this company.